A new article in the Journal of the American Medical Association said the FDA will implement AI into multiple processes.

The FDA plans to "unleash AI" on new drug evaluations in order to "radically increase efficiency in the review process." ...

Elsa” is the FDA’s new anthropomorphized AI tool which, the FDA hopes, will speed up clearances, licenses, and approvals ...

Learn more about the generative AI technology that will be used at the Food and Drug Administration (FDA) to speed up reviews ...

FDA staffers in the Center for Devices and Radiological Health told NBC News that their AI pilot, CDRH-GPT, is buggy, isn't ...

The agency has provided only limited details about its AI pilot as it advances an “aggressive timeline” for the tool's ...

The Food and Drug Administration has gone all in on AI since Martin Makary, M.D., took over the agency, most recently ...

The U.S. FDA announced this week that it deployed a generative AI tool called ELSA, now in use by staff across the agency, ...

The FDA said that the amount of imported food products has increased through years — from more than 400,000 batches imported ...

With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...

The solution automatically labels subdural collections and reports measurements such as thickness, midline shift, and volume.